Cancer Types, Treatment and Research
World's Longest Prostate Cancer Cure Rates Published at Clinical Oncology Meeting
Sarasota, Florida (PRWEB) March 6, 2009 -- Prostate Cancer Cure Rates are very important to most patients. "Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease treated with brachytherapy and supplemental conformal radiation" reports an astonishing 16-year Prostate Cancer Cure Rate, was presented by radiation oncologist and principal investigator Michael J. Dattoli, MD.
The study on Prostate Cancer Cure Rates consists of a group of 321 patients treated by Dr. Dattoli between 1992 and 1997, each of whom was diagnosed with prostate cancer categorized as at either intermediate-risk or high-risk of extra-capsular extension." 157 patients were categorized as intermediate-risk; 164 were high-risk. The stratification conforms to the National Comprehensive Cancer Network (http://www.nccn.org) guidelines and is of importance because it defines whether the cancer cells are at risk of having spread beyond the prostate gland, making "cure" by traditional surgical approaches virtually impossible.
These patients were treated with combination radiation therapy, a protocol for which Dattoli has been a noted pioneer. In the Prostate Cancer Cure Rates Study, the men were first treated with daily 3-D conformal pelvic radiation, followed by palladium-103 brachytherapy (seed implant) using generous margins.
Cure, defined as "actuarial freedom from biochemical (disease) progression" was found to be 82% at 16 years (89% for intermediate-risk patients; 74% for high-risk).
"The Prostate Cancer Cure Rates Study is encouraging for any man with intermediate or high-risk disease," notes Dattoli, "as it confirms that combination, brachytherapy-based treatment regimes have proven to be effective options for these patients. These results are far superior to any reported with surgery (traditional or robotic) or with any other treatment options, with far less risk of the complications of erectile dysfunction or incontinence."
Dattoli, and partner Richard Sorace, MD, at the Dattoli Cancer Centers & Brachytherapy Research Institute in Sarasota, Florida, have been perfecting the combination treatment protocol for over 20 years. "With the greatly advanced focal radiation technology we now have, we are confident that men - especially those with very aggressive disease - are seeing superior results to even those reported in this Prostate Cancer Cure Rates Study," Dattoli adds.
Look-back studies, such as this one, take many years to complete but are the foundation for progress in this field. "Our commitment to continuing the research and publishing these peer-reviewed studies is what will bring longer life and higher quality of life to prostate cancer patients in the future," Dattoli states.
Already the extreme and often damaging radical surgery of the past 20 years is disappearing, as men now have proven options that defeat the cancer and preserve the quality of their lives after prostate cancer.
Copies of the Prostate Cancer Cure Rates Study are available by contacting the Dattoli Cancer Center & Brachytherapy Research Institute - 877/328-8654; http://www.dattoli.com
About Dattoli Cancer Center & Brachytherapy:
The Dattoli Center has the world longest documented Prostate Cancer Cure Rates in the World. The Center, which attracts prostate cancer patients throughout the world, was created by a core group of experts in the field of prostate cancer treatment; each highly respected in the revolutionary field of brachytherapy and Intensity Modulated Radiation Therapy (IMRT) for the treatment of prostate cancer. The Dattoli Team has been refining brachytherapy prostate cancer treatment techniques since 1986 and has built the largest brachytherapy and 4D IG-IMRT program in the country.
Contact:
Ginya Carnahan, APR, CPRC
Director of Marketing & Development
Dattoli Cancer Center & Foundation
2803 Fruitville Road - Sarasota, FL 34237
800-915-1001
Related Content:
The Prostate Cancer Cure Rates Study Abstract from the Symposium, click the following link to read the article: http://www.dattoli.com/files/article/Prostate%20Cancer%20Cure%20Rates-16%20years.pdf
American Cancer Society says about Prostate Cancer Survival Rates, click the following link to read the article: http://www.cancer.org/docroot/CRI/content/CRI_2_2_6x_Prostate_Cancer_Survival_Rates.asp
American Society of Clinical Oncology on President Obama's Address to Congress: "A cure for cancer in our time", click the following link to read the article: http://www.asco.org/ASCO/News/Press+Center/Public+Policy/Cancer+Policy+News+Releases/ASCO+Statement+on+President+Obama%27s+Address+to+Congress%3A+%E2%80%9CA+cure+for+cancer+in+our+time%E2%80%9D
Older Men Urged to Consider a Drug to Prevent Prostate Cancer - NYTimes.com, click the following link to read the article: http://www.nytimes.com/2009/02/26/health/25prostate.html
New Drug Helps Slow Prostate Cancer According to a WebMD Health News, click the link to read the article: http://www.webmd.com/prostate-cancer/news/20090227/new-drug-helps-slow-prostate-cancer?src=RSS_PUBLIC
###
MORE ARTICLES:
Resource Website Directory
A helpful directory of websites and other online resources.
Cancer Awareness Jewelry: Hope and Charm Bracelets
In recent years, the ongoing battle for a breast cancer cure has gained notoriety as more and more lives have become touched by the devastating emotional and physical trials of cancer Yet where the malignancy of cancer lurks, supportive movements such as the recent popularization of Cancer Awareness Jewelry prevail, helping to sustain the fight against the disease and fortify the battle for a cure
Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers of America
FDA-approved study aimed at harnessing immune system to fight tumors.
New Leader In Cancer Community To Be Announced At Summit
The Wellness Community and Gilda’s Club Unify to Provide Support to All People Affected By Cancer
World's Longest Prostate Cancer Cure Rates Published at Clinical Oncology Meeting
A long-term study revealing the longest reported Prostate Cancer Cure Rates in the world has been presented at the annual meeting of the American Society of Clinical Oncology in Orlando, last week.
Commonly Asked Questions After Mesothelioma Treatment
There are some questions that will be on the mind of mesothelioma patients after the finish their course of therapyThe common questions are:
1- Can I be assured the cancer will never come back
Two Reproductive Factors are Important Predictors of Death from Ovarian Cancer
• Greater number of lifetime ovulations linked to higher risk of death
• Earlier age of menarche increases risk of death
Sanford Cancer Center Expands
Sanford Hematology and Oncology Moves to New Location
Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice
• Metformin is more effective than chemotherapy alone
• Study supports cancer stem cells hypothesis
• Laboratory study focused on breast cancer cells
Breast Cancer Charity Website Offers Breast Cancer Profiler Tool
Handy web-based form makes it easy for breast cancer patients to learn about their treatment options.
Alternative Lung Cancer Treatment and You
Most of the people around the world die due to cancer, and one common cause that ties them together is lung cancer The standard age for the diagnosis of this disease is sixty
Cancer Prevention is Not Rocket Science
Cancer prevention is not some kind of rocket science It is easier than you may think
Skin Cancer Charts and Graphs
Cancer is a deadly disease especially when it is not detected early There is a lot of research going on currently in trying to find possible treatments for curing cancer
Cancer Risks and Health
Cancer is the second major cause of death in the United States More than half a million of us to die of cancer every year
What Are The Risk Factors For Pancreatic Cancer?
Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year In most cases pancreatic cancer has an extremely poor survival outcome
